Navigation Links
Eppendorf Video Features Dr Andrew Holt's Work on Bioactive Leachates From Plastic Consumables
Date:12/2/2011

HAMBURG, Germany, December 2, 2011 /PRNewswire/ --

Cross reference: Picture is available via epa european pressphoto agency and can be downloaded free of charge at: http://www.presseportal.de/pm/18701/eppendorf-ag?keygroup=bild

In a well-received report in Science from 2008, Dr. Andrew Holt and his group from the University of Alberta, Canada, described how chemicals used as manufacturing additives can substantially inhibit enzymatic assays and binding studies by leaching into samples from plastic consumables. Eppendorf recently visited Dr. Holt's pharmacology lab with a film crew to ask him how experimental data can be affected and what he recommends to other scientists to ensure unaffected and reproducible results.

Daniel Wehrhahn, product manager responsible for consumables at Eppendorf, commented: 'Dr. Holt's results clearly show that using pipette tips and microcentrifuge tubes from manufacturers that can confirm the absence of critical production additives leads to experimental results which are much more reliable and reproducible. Eppendorf high quality consumables are manufactured only from virgin polypropylene certified free of plasticizers, biocides or other unwanted additives which could leach into buffers and solvents, leading to false positive or false negative results in bioassays. Our material also complies with the FDA requirements for olefin polymers.'

Launched via the Eppendorf consumables web page, YouTube and social networking sites, the new video will quickly gain worldwide exposure, helping other researchers choose plastic consumables which are best suited to their assays. Scientific background information, recent publications and application data is also available on the website.  

Eppendorf's clean-room manufacturing processes are fully automated and subject to continuous quality monitoring. In addition, fully-automated production and special optimised molds that work without slip agents - such as Oleamide or DiHEMDA - ensure that epT.I.P.S. pipette tips®, Eppendorf Tubes® and Eppendorf Plates® satisfy the requirements of demanding applications. Batch-specific purity certificates can be downloaded from the Eppendorf website.

http://www.eppendorf.com/consumables

A Video interview with Dr. Andrew Holt is available at:

http://www.youtube.com/watch?v=LR1ljpp9TDE

 

Press contact:
Eppendorf AG
Bettina Doerler
public relations officer
doerler.b@eppendorf.de
+49-40-538-01-640



'/>"/>
SOURCE Eppendorf AG
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. Eppendorf Successfully Initiates Import ban Against Nanosphere, Inc. for the Countries of the European Union
2. Eppendorf Licenses Technology for Thermal Cyclers to Bulldog Bio
3. Eppendorf AG Deploys a Strategic Information Management Solution on a Global Level
4. [video] Jacques Tizabi, CEO of Universal Detection Technology Discusses Latest Purchase Order on WallSt.nets 3-Minute Press Show
5. [video] David Brown, President and CEO of LifeVantage Corporation, Discusses Record Page Views on WallSt.nets 3-Minute Press Show
6. Video: CSL Behring Provides $1.2M Grant for Worlds First Study of Postpartum Women with VWD, Common Bleeding Disorder
7. Video: ASMANEX(R) TWISTHALER(R) 110 MCG (Mometasone Furoate Inhalation Powder) is Now Available Nationwide for the Maintenance Treatment of Asthma in Children Ages 4 to 11
8. Video: New Survey Shows Three in Four School Nurses Have Students at Risk for Severe Allergic Reactions Who Do Not Bring Auto-Injectable Epinephrine to School
9. Caliper Launches Small Animal Molecular Imaging System Enabling Real-Time Video Observation
10. Video: Keppra XR(TM) Approved in the U.S.
11. Video: Fortune 1000 Executives: New President Must Fix Education Gap
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/7/2016)... 2016 /PRNewswire/ - OncoQuest Inc. ("OncoQuest"), a biopharmaceutical ... immunotherapeutic products for the treatment of cancer, today ... Manufacturing Development Program with Cytovance Biologics ( ... oregovomab antibody product. Supported by recent positive interim ... in ovarian cancer patients, OncoQuest has engaged Cytovance ...
(Date:12/7/2016)... , Dec. 7, 2016  Biocom, the association for the ... statement below following passage of 21 st Century Cures ... November 30 by a 392-26 vote and in the Senate ... be attributed to Joe Panetta , president & CEO ... will give hope to millions of patients around the world. ...
(Date:12/7/2016)...  Genprex, Inc. a biopharmaceutical company focused on ... announced that it has retained ICR Healthcare, a ... and advisory firm, to develop and implement an ... investor relations, public relations and digital communications to ... Genprex and its lead candidate Oncoprex, which is ...
(Date:12/7/2016)... Regen BioPharma Inc. (OTCQB: RGBPP) In a recent ... team of scientists in Guangzhou, China ... of NR2F6 in patients with early cervical cancer correlates with ... cancer tissue as well as in the normal tissue surrounding ... study and the first that I am aware of that ...
Breaking Biology Technology:
(Date:12/7/2016)... 2016 According to a new market research report "Emotion ... Expression, Voice Recognition), Service, Application Area, End User, And Region - Global Forecast ... USD 6.72 Billion in 2016 to USD 36.07 Billion by 2021, at a ... Reading ... MarketsandMarkets Logo ...
(Date:12/6/2016)... Dec. 6, 2016  Zimmer Biomet Holdings, Inc. (NYSE and ... an offering of €500.0 million principal amount of its 1.414% ... of its 2.425% senior unsecured notes due 2026. ... on December 13, 2016, subject to the satisfaction of customary closing ... The Company intends to use ...
(Date:12/2/2016)... , December 1, 2016 ... type (Fingerprint, Voice), Future Technology (Iris Recognition System), ... Region - Global Forecast to 2021", published by ... 442.7 Million in 2016, and is projected to ... a CAGR of 14.06%.      (Logo: ...
Breaking Biology News(10 mins):